Monday, February 04, 2013 10:50:20 AM
In my opinion, when BMSN added Dr. Wei-Ping Min to their Scientific Advisory Board, it linked BMSN and ENTB to be in the eyes of Merk & Co. which trades on the NYSE:MRK at $41.00+ per share.
There is absolutely no way Dr. Wei-Ping Min would associate himself with BMSN unless he knew 100% that BMSN had something very worthy of note to be a part of supporting. Because of Dr. Wei-Ping Min’s credentials, if he believes that BMSN is not a scam and is very real, then I will truly trust his due diligence (DD) to do such too.
Dr. Wei-Ping Min is the inventor of siRNA therapeutics which was bought out by Merk & Co for $13.00 per share:
http://articles.marketwatch.com/2006-12-28/news/30873760_1_rna-interference-merck-sirna-therapeutics
Sirna Therapeutics holders OK $1.1 bln acquisition by Merck
SAN FRANCISCO (MarketWatch) -- Sirna Therapeutics Inc. said Thursday that its shareholders have approved the company's acquisition by Merck & Co. (US:mrk). In late October, Merck agreed to acquire San Francisco-based Sirna for $13 a share in cash, or $1.1 billion. Sirna develops therapeutics using RNA interference, which aims to treat diseases by disrupting the expression of disease-causing genes. The transaction is expected to close as soon as reasonably practicable, the company said.
Below is confirmation of BMSN making such a move to add Dr. Wei-Ping Min to their Scientific Advisory Board:
http://finance.yahoo.com/news/bio-matrix-regen-biopharma-unit-123000524.html
Dr. Wei-Ping Min is Professor at the Lawson Health Research Center in Canada. He is inventor of siRNA therapeutics in the area of immunology and cell therapy to inhibit disease modalities. He is also the founder/cofounder of several biotech companies including MedVax Pharma Corp, and ToleroTech Inc. Dr. Min brings detailed scientific and mechanistic expertise to Regen BioPharma. He earned graduate and medical degrees from Nanchang University Medical School and the PhD degree from Kyushu University.
Here’s a little bit more about Dr. Wei-Ping Min:
http://www.researchgate.net/publication/8440294_RNA_interference_a_potent_tool_for_gene-specific_therapeutics
v/r
Sterling
Sterling's Trading & Investing Strategies:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=39092516
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
